BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19091650)

  • 1. [Cervical pathology: significance and therapeutic impact of margin status].
    Michy T; Leveque J; Loussouarn D; Dravet F; Dejode M; Sagan C; Descamps P; Classe JM
    Bull Cancer; 2008 Dec; 95(12):1171-5. PubMed ID: 19091650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of cervical conization as a definitive treatment for borderline lesions of the uterine cervix].
    Matsuyama T; Tsukamoto N; Kashimura M; Iwasaka T; Saito T; Uchino H; Nakano H; Matsukuma K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2063-71. PubMed ID: 6512325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic variables predictive of residual dysplasia after cervical conization.
    Schermerhorn TJ; Hodge J; Saltzman AK; Hackett TE; Sprance HE; Harrison TA
    J Reprod Med; 1997 Apr; 42(4):189-92. PubMed ID: 9131490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease.
    Kalogirou D; Antoniou G; Karakitsos P; Botsis D; Kalogirou O; Giannikos L
    Eur J Gynaecol Oncol; 1997; 18(2):113-6. PubMed ID: 9105859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for residual disease in hysterectomy specimens after conization in early-stage cervical cancer.
    Wong AS; Li WH; Cheung TH
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():21-6. PubMed ID: 26894378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cervical intraepithelial neoplasia positive cutting edge after conization].
    Dai ZQ; Pan LY; Huang HF
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):153-4. PubMed ID: 17645859
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
    Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excisional cone as fertility-sparing treatment in early-stage cervical cancer.
    Fagotti A; Gagliardi ML; Moruzzi C; Carone V; Scambia G; Fanfani F
    Fertil Steril; 2011 Mar; 95(3):1109-12. PubMed ID: 21122837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of a new method for LEEP conization with pistol-shaped electroknife].
    Kovachev S; Nacheva A; Atanassova V; Piperkova N; Kostov I; Vasilev N
    Akush Ginekol (Sofiia); 2010; 49(5):20-5. PubMed ID: 21268398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cone margins as a predictor for residual dysplasia in post-cone hysterectomy specimens.
    Townsend DE
    Obstet Gynecol; 1994 Nov; 84(5):898. PubMed ID: 7936537
    [No Abstract]   [Full Text] [Related]  

  • 19. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
    Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.